Mirabilis Medical
Mirabilis Medical is a privately held medical device company developing technology for the treatment of uterine fibroids in women. Founded in 2004 in Bothell, Washington, the company has raised approximately $28.6M across multiple equity rounds through 2019.
- Company typePrivate
- Founded2004
- HeadquartersBothell, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Mirabilis Medical does
Mirabilis Medical is a privately held medical device company founded in 2004 and headquartered in Bothell, Washington, focused on developing technology for the treatment of uterine fibroids — a common women's health condition. The company was co-founded by Shahram Vaezy (co-founder) and Sefi Visiger (founder), and operates with a very small team of 1-10 employees. Its core product is a medical device targeting the uterine fibroid treatment market, though specific technical details about the device modality (e.g., focused ultrasound, RF ablation, cryoablation, or another mechanism) are not disclosed in the available materials. The product line is singular, with no additional products, services, or platforms documented in the input data.
The company has sustained operations for over two decades primarily through equity financing, accumulating approximately $28.6M across nine recorded funding rounds between 2007 and 2019. Its largest round was a $10.5M Series 2 in August 2007 led by Arboretum Ventures with Charter Life Sciences, Dow Venture Capital, Split Rock Partners, and vSpring Capital. A subsequent $7.0M Series 2 was led by GSR Ventures in June 2013. Later rounds (2015, 2016, and 2019) were smaller and without disclosed lead investors. Despite the long operating history, the small headcount and absence of disclosed FDA clearance, CE mark, or commercial sales suggest the company remains in a pre-commercial or highly capital-efficient development phase rather than at scaled commercialization.
Mirabilis Medical's business model is centered on regulated medical device development. Revenue mechanics for a uterine fibroid treatment device would, at commercialization, typically involve direct sales or distributor relationships to OB/GYNs, women's health centers, and hospitals — typically reimbursed under procedural CPT codes for fibroid treatment. However, no pricing models, distribution channels, customer logos, or revenue figures are disclosed in the available data. Certifications, regulatory approvals, and compliance frameworks are also not documented, leaving the company's current regulatory standing uncertain.
Mirabilis Medical firmographics
Firmographics- Name
- Mirabilis Medical
- Website
- https://mirabilismedica.com
- Company type
- Private
- Founded year
- 2004
- Headcount range
- 1–10 employees
- Short description
- Mirabilis Medical is a privately held medical device company developing technology for the treatment of uterine fibroids in women. Founded in 2004 in Bothell, Washington, the company has raised approximately $28.6M across multiple equity rounds through 2019.
- Ownership category
- akta.pro rank
Mirabilis Medical industry classification
Industry- Product category
- Gynecological Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy) (HLAKAJAF)
- akta.pro secondary industries
- Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)
Keywords
Where Mirabilis Medical is headquartered
LocationHeadquarters
- HQ city
- Bothell
- HQ country
- United States
- HQ region
- North America
Markets served
Mirabilis Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Mirabilis Medical product offering
Product offeringCore offering
Mirabilis Medical is a medical device company that develops and manufactures therapeutic devices for the treatment of uterine fibroids, a common women's health condition. The company operates from Bothell, Washington, and focuses its product efforts squarely on fibroid-treatment technology intended for clinical use by healthcare providers.
Differentiator
Problem solved
Functional benefit
Companies that use Mirabilis Medical
Customer profileIdeal customer profiles1 record
Mirabilis Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Mirabilis Medical competitors and assessment
Company assessmentDirect peers
- Insightec: Developer of Exablate, an MRI-guided focused ultrasound platform approved for uterine fibroids — the closest direct competitor to Mirabilis's non-invasive fibroid ablation approach.
- Gynesonics: Focused exclusively on minimally invasive treatments for uterine fibroids, including the Sonata system using intrauterine ultrasound-guided radiofrequency ablation.
Broad incumbents
- Hologic: Major women's health medtech incumbent with a gynecological surgical portfolio (e.g., MyoSure for fibroid/polyp removal) that competes directly with emerging fibroid ablation devices.
- Boston Scientific: Diversified medtech with gynecological surgery offerings and a long history of acquiring focused fibroid-treatment technologies, positioning it as both a competitor and potential acquirer.
- CooperSurgical: Established women's health device company offering fibroid management and endometrial ablation products, serving as a likely strategic exit path for emerging fibroid ablation developers.
Emerging players
- Minerva Surgical: Developer of the Minerva ES endometrial ablation system, a minimally invasive treatment for abnormal uterine bleeding often associated with fibroids — overlapping patient population and minimally invasive delivery model.
- Channel Medsystems: Developer of a cryoablation-based therapy for heavy menstrual bleeding linked to fibroids, representing an alternative energy-based minimally invasive modality in the same therapeutic area.
- Profound Medical: Commercializes TULSA-PRO, an MRI-guided transurethral ultrasound ablation platform, with overlapping technology underpinnings in image-guided focused-ultrasound therapy.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
Mirabilis Medical social profiles
Digital presenceMirabilis Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mirabilis Medical leadership team
Management profileNumber of profiles
Profiles2 records
Mirabilis Medical funding detail
Funding detailFunding overview
Funding rounds9 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mirabilis Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mirabilis Medical
What does Mirabilis Medical do?
Mirabilis Medical is a medical device company that develops and manufactures therapeutic devices for the treatment of uterine fibroids, a common women's health condition. The company operates from Bothell, Washington, and focuses its product efforts squarely on fibroid-treatment technology intended for clinical use by healthcare providers.
When was Mirabilis Medical founded?
Mirabilis Medical was founded in 2004. It employs 1 to 10 people.
Where is Mirabilis Medical based?
Mirabilis Medical is headquartered in Bothell, United States, in the North America region.
Who are Mirabilis Medical's main competitors?
Direct peers on record are Insightec and Gynesonics. Broad incumbents are Hologic, Boston Scientific and CooperSurgical. Emerging players are Minerva Surgical, Channel Medsystems and Profound Medical.
Does Mirabilis Medical have an API?
No public API is recorded for Mirabilis Medical.
What industry is Mirabilis Medical in?
Mirabilis Medical's product category is Gynecological Medical Devices. Its primary akta.pro industry code is HLAKAJAF, Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy), with a secondary code of HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems. Its NAICS code is 339113 and its SIC code is 3841.